Drug Report History
Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.
The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.
| Version v5-FR | Version v4-EN | |
|---|---|---|
| Language | French | English |
| Date Updated | 2022-02-04 | 2022-02-04 |
| Drug Identification Number | 02457482 | 02457482 |
| Brand name | ADENOSINE INJECTION | ADENOSINE INJECTION |
| Common or Proper name | Adenosine Injection 3 mg/mL prefilled syringe 4 mL | Adenosine Injection 3 mg/mL prefilled syringe 4 mL |
| Company Name | FRESENIUS KABI CANADA LTD | FRESENIUS KABI CANADA LTD |
| Ingredients | ADENOSINE | ADENOSINE |
| Strength(s) | 3MG | 3MG |
| Dosage form(s) | SOLUTION | SOLUTION |
| Route of administration | INTRAVENOUS INTRAVENOUS | INTRAVENOUS INTRAVENOUS |
| Packaging size | 4 mL | 4 mL |
| ATC code | C01EB | C01EB |
| ATC description | OTHER CARDIAC PREPARATIONS | OTHER CARDIAC PREPARATIONS |
| Reason for shortage | Other (Please describe in comments) | Other (Please describe in comments) |
| Anticipated start date | ||
| Actual start date | 2021-12-31 | 2021-12-31 |
| Estimated end date | 2022-02-15 | 2022-02-15 |
| Actual end date | 2022-02-03 | 2022-02-03 |
| Shortage status | Resolved | Resolved |
| Tier 3 Status | No | No |
| Company comments | Fresenius Kabi Canada regrets to advise that due to unforeseen circumstances, we will be encountering a supply interruption on our Adenosine Injection 3 mg/mL prefilled syringe 4 mL effective today, December 31, 2021 until February 15, 2022. Our Adenosine Injection 3 mg/mL prefilled syringe 2 mL format is available for substitution. | Fresenius Kabi Canada regrets to advise that due to unforeseen circumstances, we will be encountering a supply interruption on our Adenosine Injection 3 mg/mL prefilled syringe 4 mL effective today, December 31, 2021 until February 15, 2022. Our Adenosine Injection 3 mg/mL prefilled syringe 2 mL format is available for substitution. |
| Health Canada comments |